On Monday, the National Institutes of Health announced that the organization aims to invest up to $20 million in upcoming years. So the institute is going to finance researches to develop other possible replacements of human fetal tissue. The news rolled out after the Trump government warned to withdraw funding from projects that depend on it for research. It also included the study regarding a cure for HIV/AIDS. Formerly, in September, the administration began to ban NIH-financed scientists from receiving new tissue samples. On the other hand, scientists say the move stopped the study seeking for an HIV treatment.
However, Science Magazine is a pioneer to unveil the news, and the story did not rolled-out publicly. The decision is going to affect the whole nation because the U.S. South overall consists of the new HIV diagnoses. But the new initiative of NIH will expand the ongoing studies. Consequently, a team of an HIV-focused research center at scholar organizations in the U.S. intended to reduce the strain of HIV globally. NIH also announced that it would request for applications to design and process human tissue models that can sample human biology. According to NIH, it used human fetal tissue and embryonic stem cell-derived systems to detail human evolution.
While the discovery with the utilization of fetal tissue can highlight on scientific questions foundational to biomedical research. Whereas, the use of fetal tissues and stem cells taken from rejected embryos meant for IVF or other abortions has always been debatable. But it plays an essential role in the biomedical industry. Still, Trump government is opposing the research and putting it in danger. Paul Volberding, head of the AIDS Research Institute at UCSF, sent an email to Rolling Stone. In that, Paul states he doesn’t think any researcher could use human fetal tissue if there were another possible option. Additionally, the research needs human tissues to verify the results, because HIV syndrome doesn’t grow in other cells.